Carbon Monoxide-Saturated Medium for Islet Isolation

Sponsor
Medical University of South Carolina (Other)
Overall Status
Completed
CT.gov ID
NCT02567240
Collaborator
(none)
16
1
2
47
0.3

Study Details

Study Description

Brief Summary

The goal of this study is to determine whether harvesting islets using carbon monoxide (CO)-saturated mediums can protect islet cell from death after autologous islet transplantation in patients with chronic pancreatitis.

Condition or Disease Intervention/Treatment Phase
  • Other: Carbon monoxide-bubbled mediums
Phase 1/Phase 2

Detailed Description

Investigators plan to harvest human islets using carbon monoxide-saturated mediums. Survival and function of transplanted islets will be compared with islets harvested using regular mediums.

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Other
Official Title:
A Novel Approach to Harvest Islets for Autologous Islet Transplantation
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Oct 1, 2018
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Carbon monoxide-bubbled mediums

Islets will be harvested with Carbon monoxide-saturated mediums

Other: Carbon monoxide-bubbled mediums
Islets will be harvested with carbon monoxide bubbled mediums

No Intervention: Normal mediums

Islets will be harvested with regular mediums

Outcome Measures

Primary Outcome Measures

  1. Area under the curve during mixed meal tolerance test [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Chronic pancreatitis patient selected for total pancreatectomy and islet autotransplantation.

  2. Age between 18-69.

Exclusion Criteria:
  1. Had prior pancreatic surgeries.

Note: The study was initially designed only to enroll diabetes free patients. To increase enrollment, we extended the inclusion criteria by allowing patients who are pre-diabetic to participate the study. This revision was approved by the MUSC IRB on 11/10/2015.

Contacts and Locations

Locations

Site City State Country Postal Code
1 GI Surgery, Medical University of South Carolina Charleston South Carolina United States 29425

Sponsors and Collaborators

  • Medical University of South Carolina

Investigators

  • Principal Investigator: Hongjun Wang, Ph.D, Medical University of South Carolina

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT02567240
Other Study ID Numbers:
  • Pro00040035
First Posted:
Oct 2, 2015
Last Update Posted:
Jan 4, 2019
Last Verified:
Jan 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 4, 2019